Potensi Quercetin sebagai Agen Antikanker pada Kanker Payudara: Tinjauan Literatur
DOI:
https://doi.org/10.55123/sehatmas.v5i3.8310Keywords:
Quercetin, Breast Cancer, Apoptosis, Immunomodulation, ChemosensitivityAbstract
Quercetin is a plant flavonol with antioxidant, anti-inflammatory, antiproliferative, and immunomodulatory properties that may be relevant to breast cancer therapy. This literature review aims to evaluate the potential of quercetin as an anticancer agent in breast cancer and to identify its main mechanisms, therapeutic combinations, and research gaps. Literature was reviewed from PubMed, ScienceDirect, Google Scholar, and open-access journal platforms using combinations of the keywords “quercetin,” “breast cancer,” “anticancer,” “apoptosis,” and “chemotherapy sensitization.” The review focused on articles published from 2021 to 2026 and included experimental, in vivo, organoid, and recent review studies directly related to quercetin and breast cancer. The synthesis shows that quercetin inhibits breast cancer cell growth through apoptosis induction, reactive oxygen species regulation, mitochondrial membrane disruption, caspase activation, cell-cycle arrest, senescence-related pathways, and suppression of epithelial-mesenchymal transition. Combination studies indicate synergistic or chemosensitizing effects. However, most evidence remains preclinical; clinical validation, pharmacokinetic studies, and delivery-system optimization are still required.
Downloads
References
Afarin, R., Ahmadpour, F., Hatami, M., Monjezi, S., & Igder, S. (2024). Combination of etoposide and quercetin-loaded solid lipid nanoparticles potentiates apoptotic effects on MDA-MB-231 breast cancer cells. Heliyon, 10(9), e31925. https://doi.org/10.1016/j.heliyon.2024.e31925
Aghababaei, F., & Hadidi, M. (2023). Recent advances in potential health benefits of quercetin. Pharmaceuticals, 16(7), 1020. https://doi.org/10.3390/ph16071020
Almohammad Aljabr, B., Zihlif, M., Abu-Dahab, R., & Zalloum, H. (2024). Effect of quercetin on doxorubicin cytotoxicity in sensitive and resistant human MCF7 breast cancer cell lines. Biomedical Reports, 20(4), 58. https://doi.org/10.3892/br.2024.1745
Asgharian, P., Tazekand, A. P., Hosseini, K., Forouhandeh, H., Ghasemnejad, T., Ranjbar, M., & Cho, W. C. (2022). Potential mechanisms of quercetin in cancer prevention: Focus on cellular and molecular targets. Cancer Cell International, 22(1), 257. https://doi.org/10.1186/s12935-022-02677-w
Bray, F., Laversanne, M., Sung, H., Ferlay, J., Siegel, R. L., Soerjomataram, I., & Jemal, A. (2024). Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 74(3), 229-263. https://doi.org/10.3322/caac.21834
Chen, W. J., Tsai, J. H., Hsu, L. S., Lin, C. L., Hong, H. M., & Pan, M. H. (2021). Quercetin blocks the aggressive phenotype of triple-negative breast cancer by inhibiting IGF1/IGF1R-mediated EMT program. Journal of Food and Drug Analysis, 29(1), 98-112. https://doi.org/10.38212/2224-6614.3090
Fang, L., Gao, D., Wang, T., Zhao, H., Zhang, Y., & Wang, S. (2024). From nature to clinic: Quercetin’s role in breast cancer immunomodulation. Frontiers in Immunology, 15, 1483459. https://doi.org/10.3389/fimmu.2024.1483459
Fu, Z., Wei, B., Huang, Y., Yang, L., & Sun, W. (2025). Research on the mechanism by which quercetin affects ferroptosis in breast cancer cells through regulating USP9X/PIAS4. Letters in Drug Design & Discovery, 22(10), 100169. https://doi.org/10.1016/j.lddd.2025.100169
Hosseini, S. S., Ebrahimi, S. O., Haji Ghasem Kashani, M., & Reiisi, S. (2023). Study of quercetin and fisetin synergistic effect on breast cancer and potentially involved signaling pathways. Cell Biology International, 47(1), 98-109. https://doi.org/10.1002/cbin.11942
Liu, X., & Chen, Z. (2024). Quercetin suppresses cell viability in triple-negative breast cancer by targeting ORM2. American Journal of Cancer Research, 14(11), 5269-5285. https://doi.org/10.62347/DEPW1251
Meng, S., Cao, Y., Lu, L., Li, X., Sun, S., Jiang, F., Lu, J., Fan, D., Han, X., & Yao, T. (2024). Quercetin promote the chemosensitivity in organoids derived from patients with breast cancer. Breast Cancer: Targets and Therapy, 16, 993-1004. https://doi.org/10.2147/BCTT.S494901
Molani Gol, R., & Kheirouri, S. (2022). The effects of quercetin on the apoptosis of human breast cancer cell lines MCF-7 and MDA-MB-231: A systematic review. Nutrition and Cancer, 74(2), 405-422. https://doi.org/10.1080/01635581.2021.1897631
Qiu, D., Yan, X., Xiao, X., Zhang, G., Wang, Y., Cao, J., & Ma, M. (2021). To explore immune synergistic function of quercetin in inhibiting breast cancer cells. Cancer Cell International, 21(1), 632. https://doi.org/10.1186/s12935-021-02345-5
Ramos, P. S., Ferreira, C., Passos, C. L. A., Silva, J. L., & Fialho, E. (2024). Effect of quercetin and chrysin and its association on viability and cell cycle progression in MDA-MB-231 and MCF-7 human breast cancer cells. Biomedicine & Pharmacotherapy, 179, 117276. https://doi.org/10.1016/j.biopha.2024.117276
Rani Inala, M. S., & Pamidimukkala, K. (2023). Amalgamation of quercetin with anastrozole and capecitabine: A novel combination to treat breast and colon cancers - An in vitro study. Journal of Cancer Research and Therapeutics, 19(Supplement), S93-S105. https://doi.org/10.4103/jcrt.JCRT_599_20
Rhman, M. A., Devnarain, N., Khan, R., & Owira, P. M. (2022). Synergism potentiates oxidative antiproliferative effects of naringenin and quercetin in MCF-7 breast cancer cells. Nutrients, 14(16), 3437. https://doi.org/10.3390/nu14163437
Roshanazadeh, M., Babaahmadi Rezaei, H., & Rashidi, M. (2021). Quercetin synergistically potentiates the anti-metastatic effect of 5-fluorouracil on the MDA-MB-231 breast cancer cell line. Iranian Journal of Basic Medical Sciences, 24(7), 928-934. https://doi.org/10.22038/ijbms.2021.56559.12629
Ruidas, B., Sur, T. K., Das Mukhopadhyay, C., Sinha, K., Som Chaudhury, S., Sharma, P., Bhowmick, S., Majumder, R., & Saha, A. (2022). Quercetin: A silent retarder of fatty acid oxidation in breast cancer metastasis through steering of mitochondrial CPT1. Breast Cancer, 29(4), 748-760. https://doi.org/10.1007/s12282-022-01356-y
Sakao, K., Hamamoto, S., Urakawa, D., He, Z., & Hou, D. X. (2024). Anticancer activity and molecular mechanisms of acetylated and methylated quercetin in human breast cancer cells. Molecules, 29(10), 2408. https://doi.org/10.3390/molecules29102408
Shahbaz, M., Naeem, H., Momal, U., Imran, M., Alsagaby, S. A., Al Abdulmonem, W., & Al Jbawi, E. (2023). Anticancer and apoptosis inducing potential of quercetin against a wide range of human malignancies. International Journal of Food Properties, 26(1), 2590-2626. https://doi.org/10.1080/10942912.2023.2252619
Tang, H., Kuang, Y., Wu, W., Peng, B., & Fu, Q. (2023). Quercetin inhibits the metabolism of arachidonic acid by inhibiting the activity of CYP3A4, thereby inhibiting the progression of breast cancer. Molecular Medicine, 29(1), 127. https://doi.org/10.1186/s10020-023-00720-8
Yüksel, T. N., Bozgeyik, E., & Yayla, M. (2022). The effect of quercetin and quercetin-3-D-xyloside on breast cancer proliferation and migration. Journal of Basic and Clinical Health Sciences, 6(2), 569-578. https://doi.org/10.30621/jbachs.1056769
Zhang, J., Teng, F., Wu, T., Li, S., & Li, K. (2024). Quercetin inhibits chronic stress-mediated progression of triple-negative breast cancer by blocking β2-AR/ERK1/2 pathway. Biomedicine & Pharmacotherapy, 177, 116985. https://doi.org/10.1016/j.biopha.2024.116985
Zhang, J. J., Zhou, J. N., Wang, W., Lv, X. T., Li, J. T., Yang, D. L., & Liao, X. (2025). Quercetin exerts anti-breast cancer effect by inducing cellular senescence. Traditional Medicine Research, 10(10), 62. https://doi.org/10.53388/TMR20240731001
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Yekti Roro Hapsari
This work is licensed under a Creative Commons Attribution 4.0 International License.
Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa SEHATMAS (Jurnal Ilmiah Kesehatan Masyarakat) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada SEHATMAS (Jurnal Ilmiah Kesehatan Masyarakat).
